Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00116363
Recruitment Status : Unknown
Verified March 2008 by Introgen Therapeutics.
Recruitment status was:  Recruiting
First Posted : June 29, 2005
Last Update Posted : April 1, 2008
M.D. Anderson Cancer Center
Information provided by:
Introgen Therapeutics

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Primary Completion Date : No date given
  Estimated Study Completion Date : December 2006